Kevin Caliendo Initiated (XRAY) at Hold and Held Target at $42 on, Jan 17th, 2019
Kevin has made no other calls on XRAY in the last 4 months.
There is 1 other peer that has a rating on XRAY. Out of the 1 peers that are also analyzing XRAY, 0 agree with Kevin's Rating of Hold.
This is the rating of the analyst that currently disagrees with Kevin
- Robert Jones of "Goldman Sachs" Upgraded from Strong Sell to Strong Buy and Held Target at $44 on, Friday, October 19th, 2018
on: Wed, Jan 16th 2019
by: WOPRAI
on: Mon, Jan 14th 2019
by: WOPRAI
Mark May Upgraded (SNAP) to Hold and Held Target at $7 on, Jan 14th, 2019
on: Fri, Jan 11th 2019
by: WOPRAI
Jared Garber Upgraded (TXRH) to Strong Buy and Increased Target to $72 on, Jan 11th, 2019
on: Thu, Nov 29th 2018
by: WOPRAI
Jeffrey Bernstein Maintained (BLMN) at Buy with Decreased Target to $25 on, Nov 29th, 2018
on: Fri, Oct 19th 2018
by: WOPRAI
Robert Jones Upgraded (XRAY) to Strong Buy and Held Target at $44 on, Oct 19th, 2018
on: Tue, Jul 11th 2017
by: WOPRAI
Raghuram Selvaraju Initiated (XRAY) at Strong Buy and Held Target at $74 on, Jul 11th, 2017
on: Mon, Jan 05th 2015
by: WOPRAI
Randal Konik Downgraded (URBN) to Hold and Decreased Target to $35 on, Jan 5th, 2015
on: Tue, Nov 18th 2014
by: WOPRAI
Simeon Siegel Maintained (URBN) at Hold with Decreased Target to $30 on, Nov 18th, 2014
on: Tue, Nov 18th 2014
by: WOPRAI
Jen Redding Maintained (URBN) at Hold with Decreased Target to $30 on, Nov 18th, 2014
on: Tue, Nov 18th 2014
by: WOPRAI
Lorraine Hutchinson Maintained (URBN) at Strong Buy with Decreased Target to $35 on, Nov 18th, 2014
on: Tue, Nov 18th 2014
by: WOPRAI
Randal Konik Maintained (URBN) at Strong Buy with Decreased Target to $40 on, Nov 18th, 2014
on: Tue, Nov 18th 2014
by: WOPRAI